These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8087203)

  • 1. Analysis of errors in the calculation of irreversible enzyme inhibition kinetic constants.
    Gray PJ; Skinner DR; Benke KK
    Enzyme Protein; 1993; 47(3):116-23. PubMed ID: 8087203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of systematic errors on the analysis of irreversible enzyme inhibition progress curves.
    Gray P
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):181-5. PubMed ID: 2001230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Error structure as a function of substrate and inhibitor concentration in enzyme kinetic experiments.
    Mannervik B; Jakobson I; Warholm M
    Biochem J; 1986 May; 235(3):797-804. PubMed ID: 3753447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods.
    Baici A; Schenker P; Wächter M; Rüedi P
    Chem Biodivers; 2009 Mar; 6(3):261-82. PubMed ID: 19319863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor.
    Liu W; Tsou CL
    Biochim Biophys Acta; 1986 Mar; 870(2):185-90. PubMed ID: 3955054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive irreversible inhibition of enzymes in the presence of a substrate: scope and limitations.
    Kovach IM
    J Enzyme Inhib; 1991; 4(3):201-12. PubMed ID: 2037866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Algebraic least squares estimates of inhibitor constants.
    Jones ME
    J Enzyme Inhib; 1992; 5(4):317-21. PubMed ID: 1285252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of substrate inhibition kinetics in enzymatic chemical oscillations.
    Shen P; Larter R
    Biophys J; 1994 Oct; 67(4):1414-28. PubMed ID: 7819481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of kinetic data for irreversible enzyme inhibition.
    Gray PJ; Duggleby RG
    Biochem J; 1989 Jan; 257(2):419-24. PubMed ID: 2930459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An accurate method for determination of receptor-ligand and enzyme-inhibitor dissociation constants from displacement curves.
    Horovitz A; Levitzki A
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6654-8. PubMed ID: 3477796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics for the inhibition of acetylcholinesterase from human erythrocyte by cisplatin.
    Aljafari AA
    Int J Biochem Cell Biol; 1995 Sep; 27(9):965-70. PubMed ID: 7584632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
    Kamal MA; Greig NH; Alhomida AS; Al-Jafari AA
    Biochem Pharmacol; 2000 Aug; 60(4):561-70. PubMed ID: 10874131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of modification reactions at comparable enzyme and modifier concentrations.
    Zhao KY; Wang ZX
    J Theor Biol; 1996 Aug; 181(4):319-27. PubMed ID: 8949580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On a nonelementary progress curve equation and its application in enzyme kinetics.
    Golicnik M
    J Chem Inf Comput Sci; 2002; 42(2):157-61. PubMed ID: 11911683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
    Stojan J; Zorko M
    Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of enzymatic reactions. A rapid method to determine the index pI50.
    Kulhavý D; Cegan A; Komers K; Mindl J
    Z Naturforsch C J Biosci; 2002; 57(5-6):496-9. PubMed ID: 12132691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.
    Lin G; Lai CY; Liao WC
    Bioorg Med Chem; 1999 Dec; 7(12):2683-9. PubMed ID: 10658572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
    Hodge AS; Humphrey DR; Rosenberry TL
    Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust regression of enzyme kinetic data.
    Cornish-Bowden A; Endrenyi L
    Biochem J; 1986 Feb; 234(1):21-9. PubMed ID: 3707541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.